Cypherpunk Technologies, Inc. (CYPH)
1.395
-0.32
(-18.90%)
USD |
NASDAQ |
Nov 20, 12:23
Cypherpunk Technologies Cash from Investing (Quarterly) : -6.00M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -6.00M |
| June 30, 2026 | -9.544M |
| March 31, 2026 | -9.00M |
| December 31, 2025 | -97.00M |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 48.97M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.025M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.015M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -0.10M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.002M |
| June 30, 2017 | -0.001M |
| March 31, 2017 | -0.065M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Indaptus Therapeutics, Inc. | 0.0882M |
| Cue Biopharma, Inc. | 0.00 |
| Yarrow Bioscience, Inc. | -5.00M |
| Faeth Therapeutics, Inc. | 0.175M |
| Pyxis Oncology, Inc. | -37.29M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.902M |
| Cash from Financing (Quarterly) | 57.26M |
| Free Cash Flow | -132.19M |
| Free Cash Flow Per Share (Quarterly) | -0.0327 |
| Free Cash Flow to Equity (Quarterly) | -8.902M |
| Free Cash Flow to Firm (Quarterly) | -8.900M |
| Free Cash Flow Yield | -65.76% |